m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00278)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
HNF1A
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Methyltransferase-like 3 (METTL3) [WRITER]
Representative RNA-seq result indicating the expression of this target gene regulated by METTL3 | ||
Cell Line | mouse embryonic stem cells | Mus musculus |
Treatment: METTL3-/- ESCs
Control: Wild type ESCs
|
GSE145309 | |
Regulation |
|
logFC: -1.64E+00 p-value: 4.47E-50 |
More Results | Click to View More RNA-seq Results | |
Representative RIP-seq result supporting the interaction between HNF1A and the regulator | ||
Cell Line | MDA-MB-231 | Homo sapiens |
Regulation | logFC: 6.55E+00 | GSE60213 |
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | Silence of METTL3 inhibited migratory ability and Wnt activity in TPC-1 cells. METTL3 positively regulated the enrichment abundance of Hepatocyte nuclear factor 1-alpha (HNF1A/TCF1) in anti-IGF2BP2. TCF1 was responsible for METTL3-regulated thyroid carcinoma progression via the m6A methylation. | |||
Target Regulation | Up regulation | |||
Responsed Disease | Thyroid Cancer | ICD-11: 2D10 | ||
Pathway Response | Wnt signaling pathway | hsa04310 | ||
Cell Process | Cell migratory | |||
In-vitro Model | B-CPAP | Thyroid gland carcinoma | Homo sapiens | CVCL_0153 |
Nthy-ori 3-1 | Normal | Homo sapiens | CVCL_2659 | |
TPC-1 | Thyroid gland papillary carcinoma | Homo sapiens | CVCL_6298 | |
Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) [READER]
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | Silence of METTL3 inhibited migratory ability and Wnt activity in TPC-1 cells. METTL3 positively regulated the enrichment abundance of Hepatocyte nuclear factor 1-alpha (HNF1A/TCF1) in anti-IGF2BP2. TCF1 was responsible for METTL3-regulated thyroid carcinoma progression via the m6A methylation. | |||
Target Regulation | Up regulation | |||
Responsed Disease | Thyroid Cancer | ICD-11: 2D10 | ||
Pathway Response | Wnt signaling pathway | hsa04310 | ||
Cell Process | Cell migratory | |||
In-vitro Model | B-CPAP | Thyroid gland carcinoma | Homo sapiens | CVCL_0153 |
Nthy-ori 3-1 | Normal | Homo sapiens | CVCL_2659 | |
TPC-1 | Thyroid gland papillary carcinoma | Homo sapiens | CVCL_6298 | |
Thyroid Cancer [ICD-11: 2D10]
In total 2 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | Silence of METTL3 inhibited migratory ability and Wnt activity in TPC-1 cells. METTL3 positively regulated the enrichment abundance of Hepatocyte nuclear factor 1-alpha (HNF1A/TCF1) in anti-IGF2BP2. TCF1 was responsible for METTL3-regulated thyroid carcinoma progression via the m6A methylation. | |||
Responsed Disease | Thyroid Cancer [ICD-11: 2D10] | |||
Target Regulator | Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) | READER | ||
Target Regulation | Up regulation | |||
Pathway Response | Wnt signaling pathway | hsa04310 | ||
Cell Process | Cell migratory | |||
In-vitro Model | B-CPAP | Thyroid gland carcinoma | Homo sapiens | CVCL_0153 |
Nthy-ori 3-1 | Normal | Homo sapiens | CVCL_2659 | |
TPC-1 | Thyroid gland papillary carcinoma | Homo sapiens | CVCL_6298 | |
Experiment 2 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | Silence of METTL3 inhibited migratory ability and Wnt activity in TPC-1 cells. METTL3 positively regulated the enrichment abundance of Hepatocyte nuclear factor 1-alpha (HNF1A/TCF1) in anti-IGF2BP2. TCF1 was responsible for METTL3-regulated thyroid carcinoma progression via the m6A methylation. | |||
Responsed Disease | Thyroid Cancer [ICD-11: 2D10] | |||
Target Regulator | Methyltransferase-like 3 (METTL3) | WRITER | ||
Target Regulation | Up regulation | |||
Pathway Response | Wnt signaling pathway | hsa04310 | ||
Cell Process | Cell migratory | |||
In-vitro Model | B-CPAP | Thyroid gland carcinoma | Homo sapiens | CVCL_0153 |
Nthy-ori 3-1 | Normal | Homo sapiens | CVCL_2659 | |
TPC-1 | Thyroid gland papillary carcinoma | Homo sapiens | CVCL_6298 | |